0SUM37Z
Supplement Metatarsal-Phalangeal Joint, Right to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | S Lower Joints |
| Operation | U Supplement |
| Body Part | M Metatarsal-Phalangeal Joint, Right |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a lower joint that is still structurally present but needs additional support. Ligament reconstruction, such as an ACL or PCL graft in the knee, is the classic example, along with labral augmentation in the hip or cartilage grafting. Unlike replacement, the native joint stays in place; the surgery strengthens a weakened or torn portion of it.
Grafts can come from the patient's own tissue, a donor, or synthetic material, and the choice often depends on age, activity level, and the structure being reinforced. These procedures are common after athletic injuries, aiming to restore stability so the joint can withstand normal or athletic loads again.
Anatomy & Axis Detail
Metatarsal-Phalangeal Joint, Right
The right metatarsal-phalangeal joint, most often the first MTP joint at the base of the great toe, bears substantial load during push-off and is prone to cartilage wear from hallux rigidus or capsular attenuation from bunion deformities; supplementing this joint involves adding cartilage substitute or ligamentous graft material to preserve motion when the joint surface is compromised but not destroyed enough to warrant fusion or replacement. This conservative-leaning option is attractive for active patients who want to retain toe dorsiflexion for a normal gait cycle. Since the great toe MTP joint differs biomechanically from the lesser toe joints, the operative report should specify which metatarsal-phalangeal joint received the graft and what material was used.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders assign Supplement when documentation shows material was added to reinforce an existing body part rather than substitute for it, which requires confirming the native structure was not removed. Graft type, whether autograft, allograft, or synthetic, factors into the device value. A recurring mistake is coding a ligament reconstruction as Repair when a formal graft was placed, or conversely coding Supplement when the graft actually replaced a joint surface rather than reinforcing intact tissue.